Vaxcyte Statistics
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
55.39-2.97 (-5.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vaxcyte by the numbers
Vaxcyte has a market capitalization of $8.77 billion based on 158.30M shares outstanding. With trailing EPS of $-8.05, Vaxcyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 4.2% below its 200-day average.
Average daily trading volume is 2.19M shares, or about $121.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PCVX valuation vs. peer median
| Metric | PCVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.77B | $9.50B | -8% |
| Avg. volume | 2.19M | 1.33M | +65% |
Peer median across 8 companies: KRYS, KYMR, QGEN, HALO, CGON, RGEN, TWST, IMVT.
Valuation
- Market cap
- $8.77B
- EPS (TTM)
- $-8.05
- Shares outstanding
- 158.30M
Price and trading
- Previous close
- 58.36
- Open
- 57.77
- Day range
- 55.27 – 58.48
- 52-week range
- 42.40 – 90.75
- 52-week change
- +15.93%
- Beta
- —
- Volume
- 1.91M
- Average volume
- 2.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 8.77B
- Forward Pe
- -8.06
- Eps
- -8.05
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 90.75
- Week52 Low
- 42.40
- Avg Volume
- 2.19M
- Shares Outstanding
- 158.30M
- Ma50
- 62.11
- Ma200
- 57.79
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -38.96%
- Pct From52w Low
- 30.64%